A First-in-Human Phase 1 Study of Plasmalogen Precursor PPI-1011 in Healthy Adult Volunteers to Assess Safety, Tolerability, and Pharmacokinetics
Clinical trial NCT05969977 · UNKNOWN
Trial details
- NCT number
- NCT05969977
- Sponsor
- MED-LIFE DISCOVERIES LP
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-29
- Primary completion
- 2023-11-30
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.